112 related articles for article (PubMed ID: 17157817)
1. Optical mapping of ventricular arrhythmias in LQTS mice with SCN5A mutation N1325S.
Tian XL; Cheng Y; Zhang T; Liao ML; Yong SL; Wang QK
Biochem Biophys Res Commun; 2007 Jan; 352(4):879-83. PubMed ID: 17157817
[TBL] [Abstract][Full Text] [Related]
2. Effects of L-type Ca2+ channel antagonism on ventricular arrhythmogenesis in murine hearts containing a modification in the Scn5a gene modelling human long QT syndrome 3.
Thomas G; Gurung IS; Killeen MJ; Hakim P; Goddard CA; Mahaut-Smith MP; Colledge WH; Grace AA; Huang CL
J Physiol; 2007 Jan; 578(Pt 1):85-97. PubMed ID: 17110414
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms by which SCN5A mutation N1325S causes cardiac arrhythmias and sudden death in vivo.
Tian XL; Yong SL; Wan X; Wu L; Chung MK; Tchou PJ; Rosenbaum DS; Van Wagoner DR; Kirsch GE; Wang Q
Cardiovasc Res; 2004 Feb; 61(2):256-67. PubMed ID: 14736542
[TBL] [Abstract][Full Text] [Related]
4. LQTS mutation N1325S in cardiac sodium channel gene SCN5A causes cardiomyocyte apoptosis, cardiac fibrosis and contractile dysfunction in mice.
Zhang T; Yong SL; Drinko JK; Popović ZB; Shryock JC; Belardinelli L; Wang QK
Int J Cardiol; 2011 Mar; 147(2):239-45. PubMed ID: 19762097
[TBL] [Abstract][Full Text] [Related]
5. Effect of pacing and mexiletine on dispersion of repolarisation and arrhythmias in DeltaKPQ SCN5A (long QT3) mice.
Fabritz L; Kirchhof P; Franz MR; Nuyens D; Rossenbacker T; Ottenhof A; Haverkamp W; Breithardt G; Carmeliet E; Carmeliet P
Cardiovasc Res; 2003 Mar; 57(4):1085-93. PubMed ID: 12650887
[TBL] [Abstract][Full Text] [Related]
6. Induction of high STAT1 expression in transgenic mice with LQTS and heart failure.
Wu L; Archacki SR; Zhang T; Wang QK
Biochem Biophys Res Commun; 2007 Jun; 358(2):449-54. PubMed ID: 17490620
[TBL] [Abstract][Full Text] [Related]
7. Knock-in gain-of-function sodium channel mutation prolongs atrial action potentials and alters atrial vulnerability.
Blana A; Kaese S; Fortmüller L; Laakmann S; Damke D; van Bragt K; Eckstein J; Piccini I; Kirchhefer U; Nattel S; Breithardt G; Carmeliet P; Carmeliet E; Schotten U; Verheule S; Kirchhof P; Fabritz L
Heart Rhythm; 2010 Dec; 7(12):1862-9. PubMed ID: 20728579
[TBL] [Abstract][Full Text] [Related]
8. Paced electrogram fractionation analysis of arrhythmogenic tendency in DeltaKPQ Scn5a mice.
Head CE; Balasubramaniam R; Thomas G; Goddard CA; Lei M; Colledge WH; Grace AA; Huang CL
J Cardiovasc Electrophysiol; 2005 Dec; 16(12):1329-40. PubMed ID: 16403066
[TBL] [Abstract][Full Text] [Related]
9. Gating properties of SCN5A mutations and the response to mexiletine in long-QT syndrome type 3 patients.
Ruan Y; Liu N; Bloise R; Napolitano C; Priori SG
Circulation; 2007 Sep; 116(10):1137-44. PubMed ID: 17698727
[TBL] [Abstract][Full Text] [Related]
10. Effects of flecainide and quinidine on arrhythmogenic properties of Scn5a+/Delta murine hearts modelling long QT syndrome 3.
Stokoe KS; Thomas G; Goddard CA; Colledge WH; Grace AA; Huang CL
J Physiol; 2007 Jan; 578(Pt 1):69-84. PubMed ID: 17023504
[TBL] [Abstract][Full Text] [Related]
11. Autonomic modulation and antiarrhythmic therapy in a model of long QT syndrome type 3.
Fabritz L; Damke D; Emmerich M; Kaufmann SG; Theis K; Blana A; Fortmüller L; Laakmann S; Hermann S; Aleynichenko E; Steinfurt J; Volkery D; Riemann B; Kirchhefer U; Franz MR; Breithardt G; Carmeliet E; Schäfers M; Maier SK; Carmeliet P; Kirchhof P
Cardiovasc Res; 2010 Jul; 87(1):60-72. PubMed ID: 20110334
[TBL] [Abstract][Full Text] [Related]
12. Arrhythmogenic consequences of Na+ channel mutations in the transmurally heterogeneous mammalian left ventricle: analysis of the I1768V SCN5A mutation.
Flaim SN; Giles WR; McCulloch AD
Heart Rhythm; 2007 Jun; 4(6):768-78. PubMed ID: 17556201
[TBL] [Abstract][Full Text] [Related]
13. A trafficking defective, Brugada syndrome-causing SCN5A mutation rescued by drugs.
Valdivia CR; Tester DJ; Rok BA; Porter CB; Munger TM; Jahangir A; Makielski JC; Ackerman MJ
Cardiovasc Res; 2004 Apr; 62(1):53-62. PubMed ID: 15023552
[TBL] [Abstract][Full Text] [Related]
14. Propranolol prevents life-threatening arrhythmias in LQT3 transgenic mice: implications for the clinical management of LQT3 patients.
Calvillo L; Spazzolini C; Vullo E; Insolia R; Crotti L; Schwartz PJ
Heart Rhythm; 2014 Jan; 11(1):126-32. PubMed ID: 24135497
[TBL] [Abstract][Full Text] [Related]
15. A novel SCN5A arrhythmia mutation, M1766L, with expression defect rescued by mexiletine.
Valdivia CR; Ackerman MJ; Tester DJ; Wada T; McCormack J; Ye B; Makielski JC
Cardiovasc Res; 2002 Aug; 55(2):279-89. PubMed ID: 12123767
[TBL] [Abstract][Full Text] [Related]
16. Intracellular calcium attenuates late current conducted by mutant human cardiac sodium channels.
Potet F; Beckermann TM; Kunic JD; George AL
Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):933-41. PubMed ID: 26022185
[TBL] [Abstract][Full Text] [Related]
17. Purkinje Cells as Sources of Arrhythmias in Long QT Syndrome Type 3.
Iyer V; Roman-Campos D; Sampson KJ; Kang G; Fishman GI; Kass RS
Sci Rep; 2015 Aug; 5():13287. PubMed ID: 26289036
[TBL] [Abstract][Full Text] [Related]
18. Abrupt rate accelerations or premature beats cause life-threatening arrhythmias in mice with long-QT3 syndrome.
Nuyens D; Stengl M; Dugarmaa S; Rossenbacker T; Compernolle V; Rudy Y; Smits JF; Flameng W; Clancy CE; Moons L; Vos MA; Dewerchin M; Benndorf K; Collen D; Carmeliet E; Carmeliet P
Nat Med; 2001 Sep; 7(9):1021-7. PubMed ID: 11533705
[TBL] [Abstract][Full Text] [Related]
19. Arrhythmogenic substrate and its modification by nicorandil in a murine model of long QT type 3 syndrome.
Hothi SS; Booth SW; Sabir IN; Killeen MJ; Simpson F; Zhang Y; Grace AA; Huang CL
Prog Biophys Mol Biol; 2008; 98(2-3):267-80. PubMed ID: 19351517
[TBL] [Abstract][Full Text] [Related]
20. Long QT syndrome: biophysical and pharmacologic mechanisms in LQT3.
Bennett PB
J Cardiovasc Electrophysiol; 2000 Jul; 11(7):819-22. PubMed ID: 10921801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
